Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: A retrospective case series.

被引：0
|
作者：
Chamberlain, Marc C.
Kim, Bryan T.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e13538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13538
引用
收藏
页数：5
相关论文
共 50 条
  • [21] NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: EXPLORATORY ANALYSIS OF MGMT METHYLATION STATUS AND BASELINE CORTICOSTEROID USE
    Weller, Michael
    Reardon, David
    Brandes, Alba
    Sampson, John
    Mulholland, Paul
    Wick, Antje
    Baehring, Joachim
    Ahluwalia, Manmeet
    Roth, Patrick
    Baehr, Oliver
    Phuphanich, Surasak
    Sepulveda, Juan
    De Souza, Paul
    Sahebjam, Solmaz
    Potter, Von
    Tatsuoka, Kay
    Taitt, Corina
    Zwirtes, Ricardo
    Omuro, Antonio
    Lim, Michael
    NEURO-ONCOLOGY, 2019, 21 : 12 - 12
  • [22] The unavoidable pressure ulcer: A retrospective case series.
    Levine, J. M.
    Humphrey, S.
    Lebovits, S.
    Fogel, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S138 - S138
  • [23] Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study
    Morisse, M. C.
    Etienne-Selloum, N.
    Bello-Roufai, D.
    Blonski, M.
    Taillandier, L.
    Lorgis, V.
    Noel, G.
    Ahle, G.
    Duran-Pena, A.
    Boone, M.
    Chauffert, B.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 144 (02) : 419 - 426
  • [24] Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study
    M. C. Morisse
    N. Etienne-Selloum
    D. Bello-Roufai
    M. Blonski
    L. Taillandier
    V. Lorgis
    G. Noël
    G. Ahle
    A. Durán-Peña
    M. Boone
    B. Chauffert
    Journal of Neuro-Oncology, 2019, 144 : 419 - 426
  • [25] Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice
    Desjardins, Annick
    Herndon, James E., II
    McSherry, Frances
    Ravelo, Arliene
    Lipp, Eric S.
    Healy, Patrick
    Peters, Katherine B.
    Sampson, John H.
    Randazzo, Dina
    Sommer, Nicolas
    Friedman, Allan H.
    Friedman, Henry S.
    HEALTH SCIENCE REPORTS, 2019, 2 (04)
  • [26] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    Schiff, David
    Purow, Benjamin
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (04): : 186 - 187
  • [27] Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab
    Pope, W. B.
    Xia, Q.
    Paton, V. E.
    Das, A.
    Hambleton, J.
    Kim, H. J.
    Huo, J.
    Brown, M. S.
    Goldin, J.
    Cloughesy, T.
    NEUROLOGY, 2011, 76 (05) : 432 - 437
  • [28] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    J. N. Jakobsen
    T. Urup
    K. Grunnet
    A. Toft
    M. D. Johansen
    S. H. Poulsen
    I. J. Christensen
    A. Muhic
    H. S. Poulsen
    Journal of Neuro-Oncology, 2018, 137 : 439 - 446
  • [29] Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
    Wefel, Jeffrey S.
    Cloughesy, Timothy
    Zazzali, James L.
    Zheng, Maoxia
    Prados, Michael
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Das, Asha
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2011, 13 (06) : 660 - 668
  • [30] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    David Schiff
    Benjamin Purow
    Nature Clinical Practice Oncology, 2008, 5 : 186 - 187
12345